Procter & Gamble Health (PGHL.NS) Azione Prezzo
Procter & Gamble Health Prezzo
Il fatturato è cresciuto a un tasso composto del 7,9% annuo negli ultimi 19 anni, raggiungendo 14,08 miliardi INR. L'utile per azione è cresciuto del 4,8% all'anno negli ultimi 19 anni. Il margine netto di Procter & Gamble Health si attesta al 23,2%, in aumento rispetto al 17,3% di alcuni anni fa. Procter & Gamble Health offre attualmente un rendimento da dividendo di circa il 2,31%. Il payout ratio è pari a circa il 63% degli utili. Il dividendo è cresciuto del 10,7% all'anno negli ultimi 18 anni. Gli analisti fissano un target di prezzo mediano di 5339,70 INR, ovvero il 1,3% sotto il prezzo attuale. Su 7 analisti, 6 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Procter & Gamble Health Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
Procter & Gamble Health Azione e analisi azionaria
Domande frequenti sull'azione Procter & Gamble Health
The business model of Procter & Gamble Health Ltd revolves around manufacturing and selling a wide range of consumer healthcare products. As a subsidiary of Procter & Gamble Company, it focuses on developing and marketing products that help consumers improve their health and well-being. Procter & Gamble Health Ltd aims to offer innovative pharmaceuticals, over-the-counter medications, and personal care products to meet the needs of its customers. By consistently delivering high-quality and reliable products, the company strives to maintain a strong market presence and generate sustainable revenue growth.
Procter & Gamble Health Ltd is primarily active in the healthcare industry.
The main competitors of Procter & Gamble Health Ltd in the market are Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, and Sanofi.
Procter & Gamble Health Ltd, previously known as Merck Limited, is a leading healthcare company in India. The company has a rich history that dates back to 1967 when it was incorporated as a joint venture between Merck & Co. Inc. (USA) and a local promoter group. Over the years, it has established itself as a trusted name in the pharmaceutical industry, providing a wide range of innovative healthcare solutions. Procter & Gamble Health Ltd focuses on delivering high-quality products in areas such as vitamins, cough drops, and over-the-counter medicines. With its commitment to improving the well-being of consumers, the company continues to play a vital role in shaping the healthcare landscape in India.
Procter & Gamble Health Ltd has achieved various significant milestones throughout its history. With a rich legacy spanning decades, the company has successfully established itself as a leader in the healthcare industry. It has consistently delivered innovative and high-quality healthcare solutions, contributing to improved well-being and quality of life for consumers worldwide. Procter & Gamble Health Ltd has continually expanded its product portfolio, ranging from over-the-counter medications and nutritional supplements to personal care products. Additionally, the company has achieved noteworthy financial growth, expanding its market reach and generating substantial value for its shareholders. Procter & Gamble Health Ltd's commitment to excellence and continuous innovation has solidified its position as a trusted and respected name in the healthcare sector.
Procter & Gamble Health Ltd is primarily present in India.
Procter & Gamble Health Ltd represents strong values and a corporate philosophy centered around improving lives through innovative healthcare solutions. With a commitment to delivering quality health and wellness products, the company strives to enhance the well-being of individuals and families worldwide. Procter & Gamble Health Ltd emphasizes integrity, excellence, and collaboration in all aspects of its operations. By continuously investing in research and development, the company aims to provide trusted and effective healthcare solutions to meet the diverse needs of consumers. With its customer-centric approach and dedication to advancing healthcare, Procter & Gamble Health Ltd is a leading player in the industry.
Gli analisti fissano attualmente un prezzo obiettivo medio di 5339,70 INR per l’azione Procter & Gamble Health (mediana: 5339,70 INR), pari a -1,3 % rispetto all’ultimo prezzo. Il consenso si basa su 7 giudizi di analisti.
7 analisti valutano attualmente l’azione Procter & Gamble Health: 6 raccomandano l’acquisto, 1 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per Procter & Gamble Health ricavi pari a 13,52 miliardi INR e un utile per azione di 189,89 INR.
Convertita al tasso di cambio attuale, l’azione Procter & Gamble Health quota 50,98 EUR (5411,00 INR).
L’azione Procter & Gamble Health (PGHL.NS) è quotata su 2 borse, tra cui: NSE (Indien) (PGHL.NS).
Procter & Gamble Health Ltd is a leading company in the health and personal care industry, offering a wide range of innovative products and solutions. The company offers products in various categories, including baby care, skincare, oral care, and women’s health. Its baby care products include diapers, wet wipes, baby soap, and baby oil. The skincare products include a wide range of items such as moisturizers, body lotions, and cleansers. The oral care products include toothpaste, mouthwash, and dental floss. The women’s health products include feminine hygiene products such as sanitary pads, tampons, and panty liners. Procter & Gamble Health Ltd strives to develop its products based on innovation, quality, and safety. The company invests in research and development to ensure that its products meet the highest quality standards. It also engages in clinical studies to verify the effectiveness and safety of its products. In addition to selling retail products, Procter & Gamble Health Ltd also operates an extensive business in the medical professionals’ sector. The company conducts educational programs for doctors and medical practitioners to improve their understanding of the products and their application. It also collaborates with leading medical institutions to advance research and innovation in the healthcare industry. Procter & Gamble Health Ltd has a strong global presence and operates in more than 180 countries. The company has a strong market position in the major markets of Europe, Americas, Asia, and the Middle East. It also works with leading distribution partners in all regions to ensure that its products are available worldwide. Overall, Procter & Gamble Health Ltd has a successful business model based on the development and provision of innovative health and personal care products. The company is committed to quality and safety and engages in research and development as well as medical education programs to strengthen its position in the industry. With a large global presence and a diverse product portfolio, Procter & Gamble Health Ltd is well-positioned to continue its successful growth and meet the needs of its customers worldwide.
Il attesa fatturato di Procter & Gamble Health ammonta a 13,52 miliardi INR. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Procter & Gamble Health ammonta a 3,15 miliardi INR. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Procter & Gamble Health è attualmente 28,50. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Procter & Gamble Health.
Il rapporto prezzo/fatturato (P/S) di Procter & Gamble Health è attualmente 6,64. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Procter & Gamble Health.
Il Quality Score AlleAktien per Procter & Gamble Health è 6/10.
L'ISIN di Procter & Gamble Health è INE199A01012. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il ticker di Procter & Gamble Health è PGHL.NS. Con questo simbolo di borsa vengono negoziate le azioni Procter & Gamble Health in borsa.
Azione Procter & Gamble Health
Gruppo di pari di Procter & Gamble Health
Procter & Gamble Health Ticker
Procter & Gamble Health FIGI
Altre metriche e analisi di Procter & Gamble Health in Deep Dive.
La nostra analisi azionaria dell'azione Procter & Gamble Health include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Procter & Gamble Health. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: